The Clorox Company (NYSE:CLX) Shares Sold by Barclays PLC

Barclays PLC lowered its position in The Clorox Company (NYSE:CLX - Free Report) by 53.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 300,843 shares of the company's stock after selling 350,454 shares during the quarter. Barclays PLC owned about 0.24% of Clorox worth $48,859,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Brooklyn Investment Group grew its stake in shares of Clorox by 163.8% in the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company's stock valued at $25,000 after buying an additional 95 shares during the period. Redwood Park Advisors LLC acquired a new position in Clorox in the fourth quarter valued at approximately $26,000. Millstone Evans Group LLC purchased a new position in Clorox in the fourth quarter worth approximately $31,000. Asset Planning Inc acquired a new stake in Clorox during the fourth quarter worth $32,000. Finally, Aster Capital Management DIFC Ltd purchased a new stake in Clorox in the fourth quarter valued at $33,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Price Performance

CLX stock traded up $2.80 during trading on Friday, reaching $139.60. 948,624 shares of the company were exchanged, compared to its average volume of 1,304,252. The company has a market cap of $17.20 billion, a P/E ratio of 38.14, a PEG ratio of 2.62 and a beta of 0.61. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The stock's 50 day moving average price is $146.57 and its 200 day moving average price is $156.40. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter in the prior year, the firm posted $2.16 earnings per share. As a group, analysts predict that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be given a $1.22 dividend. The ex-dividend date is Wednesday, April 23rd. This represents a $4.88 annualized dividend and a dividend yield of 3.50%. Clorox's dividend payout ratio is presently 133.33%.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on CLX shares. DA Davidson dropped their price target on shares of Clorox from $171.00 to $169.00 and set a "neutral" rating for the company in a research report on Wednesday, February 5th. UBS Group lowered their target price on Clorox from $176.00 to $154.00 and set a "neutral" rating for the company in a report on Thursday. Evercore ISI boosted their price target on shares of Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Barclays decreased their price target on Clorox from $139.00 to $134.00 and set an "underweight" rating for the company in a report on Friday, April 11th. Finally, Royal Bank of Canada restated a "sector perform" rating and set a $150.00 target price on shares of Clorox in a research note on Thursday, January 30th. Three research analysts have rated the stock with a sell rating, ten have given a hold rating and one has given a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus target price of $153.83.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.